New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...
ALNY stock gains after submitting a regulatory application in the EU, seeking the approval of vutrisiran to treat ATTR ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced the submission of a Type II Variation to the European Medicines Agency (EMA) for ...
Ability Biologics ("Ability") is proud to announce a new partnership with Mila - Quebec Artificial Intelligence Institute. This partnership will bring together Mila's world-renowned network of experts ...
Alnylam Pharmaceuticals (ALNY) announced the submission of a Type II Variation to the European Medicines Agency for vutrisiran, an ...
AlphaFold’s developers were awarded science’s top prize. Elsewhere, J&J is shuttering an intriguing cancer study and Alnylam is asking for approval of a drug that could rival a Pfizer blockbuster.
Alnylam stock is in flat base and is offering a potential early entry. The biopharma company is hosting its Investor Day as earnings loom.
RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (ALNY) announced Wednesday the submission of its supplemental New Drug ...
The small interfering RNA (siRNA) agent vutrisiran has beneficial effects on cardiac biomarkers that are seen as early as 6 months in patients with transthyretin amyloidosis with cardiomyopathy ...
In September, Indian markets enjoyed a series of record highs, but on the final trading day of the month, investors opted for profit booking, leading to a sharp correction. Both the Nifty 50 and ...
US RNAi therapeutics company Alnylam Pharmaceuticals (Nasdaq: ALNY) has released two new data sets from the HELIOS-B Phase III study of Amvuttra(vutrisiran), an investigational RNAi therapeutic in ...
Lewis Hamilton has revealed a 'terrifying' meeting with Mercedes team principal Toto Wolff that occurred before the start of the season. Hamilton is a seven-time world champion in Formula 1, and has ...